1. |
王健东, 全志伟. 胆管癌基础研究现状[J]. 中国实用外科杂志, 2008, 28(4):297-300.
|
2. |
Hezel AF, Zhu AX. Systemic therapy for biliary tract cancers[J]. Oncologist, 2008, 13(4):415-423.
|
3. |
Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma:audit of 52 consecutive cases[J]. Ann Surg, 2003, 238(5):720-727.
|
4. |
Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma:analysis of 46 patients[J]. Arch Surg, 2004, 139(5):514-523.
|
5. |
陈中, 晏建军, 黄亮, 等. 肝内胆管细胞癌预后因素分析[J]. 中华肝胆外科杂志, 2006, 12(10):654-656.
|
6. |
陶连元, 何小东, 高飞, 等. 肝外胆管癌的临床病理与预后分析[J]. 肝胆外科杂志, 2011, 19(4):251-253.
|
7. |
董娜娜, 段晓峰, 张倜, 等. 103例肝内胆管癌临床病理及诊治分析[J]. 中国肿瘤临床, 2012, 39(6):340-342, 347.
|
8. |
陆凯, 张博, 董立巍, 等. 中下段胆管癌的预后影响因素分析[J]. 现代生物医学进展, 2012, 12(26):5068-5071.
|
9. |
张佳, 吴硕东, 孔静. 肝内胆管细胞癌的早期诊断[J]. 临床误诊误治, 2010, 23(增刊1):49-49.
|
10. |
Khan SA, Davidson BR, Gold IR, et al. Guide lines for the diagnosis and treatment of cholangiocarcinoma:consensus document[J]. Gut, 2002, 51(Suppl 6):s7-s9.
|
11. |
Ribero D, Amisano M, Lo Tesoriere R, et al. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma[J]. Ann Surg, 2011, 254(5):776-781.
|
12. |
陆凯. 不同部位胆管癌的临床病理特征与预后关系分析[D]. 上海:第二军医大学, 2007:1-55.
|
13. |
De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma:an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol, 2011, 29(23):3140-3145.
|
14. |
Shiba H, Ishida Y, Wakiyama S, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection[J]. J Gastrointest Surg, 2009, 13(9):1636-1642.
|
15. |
石俊方, 杨椿. 输血对恶性肿瘤手术预后的影响[J]. 中国肿瘤临床, 1991, 18(增刊1):318-319.
|
16. |
李书红, 王俊, 张金野, 等. 手术切除肝内胆管细胞癌预后相关因素分析[J]. 中华肿瘤防治杂志, 2011, 18(24):1956-1959.
|
17. |
张梅英, 温志立, 许艳华. ALP、γ-GT和CHE检测在慢性乙型肝炎、肝硬化、肝癌、胆道疾病中的临床意义[J]. 南昌大学学报·医学版, 2012, 52(2):34-36.
|